152 related articles for article (PubMed ID: 16834573)
21. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences.
Zimmermann C; Prévost-Blondel A; Blaser C; Pircher H
Eur J Immunol; 1999 Jan; 29(1):284-90. PubMed ID: 9933110
[TBL] [Abstract][Full Text] [Related]
22. Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8+ T cells against tumors.
Huck SP; Tang SC; Andrew KA; Yang J; Harper JL; Ronchese F
Cancer Immunol Immunother; 2008 Jan; 57(1):63-71. PubMed ID: 17609951
[TBL] [Abstract][Full Text] [Related]
23. The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice.
Zhao L; Ching LM; Kestell P; Baguley BC
Br J Cancer; 2002 Aug; 87(4):465-70. PubMed ID: 12177785
[TBL] [Abstract][Full Text] [Related]
24. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.
Yi KH; Nechushtan H; Bowers WJ; Walker GR; Zhang Y; Pham DG; Podack ER; Federoff HJ; Tolba KA; Rosenblatt JD
Cancer Res; 2007 Oct; 67(20):10027-37. PubMed ID: 17942937
[TBL] [Abstract][Full Text] [Related]
25. Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity.
Kalyanasundaram Bhanumathy K; Zhang B; Xie Y; Xu A; Tan X; Xiang J
J Gene Med; 2015; 17(8-9):153-60. PubMed ID: 26212685
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy.
Joseph WR; Cao Z; Mountjoy KG; Marshall ES; Baguley BC; Ching LM
Cancer Res; 1999 Feb; 59(3):633-8. PubMed ID: 9973211
[TBL] [Abstract][Full Text] [Related]
27. Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursors.
Hermans IF; Daish A; Yang J; Ritchie DS; Ronchese F
Cancer Res; 1998 Sep; 58(17):3909-17. PubMed ID: 9731502
[TBL] [Abstract][Full Text] [Related]
28. Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
Cao Z; Baguley BC; Ching LM
Cancer Res; 2001 Feb; 61(4):1517-21. PubMed ID: 11245459
[TBL] [Abstract][Full Text] [Related]
29. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
30. Induction of tumour necrosis factor and interferon-gamma in cultured murine splenocytes by the antivascular agent DMXAA and its metabolites.
Wang LC; Reddy CB; Baguley BC; Kestell P; Sutherland R; Ching LM
Biochem Pharmacol; 2004 Mar; 67(5):937-45. PubMed ID: 15104247
[TBL] [Abstract][Full Text] [Related]
31. Antigen incorporated in virus-like particles is delivered to specific dendritic cell subsets that induce an effective antitumor immune response in vivo.
Li K; Peers-Adams A; Win SJ; Scullion S; Wilson M; Young VL; Jennings P; Ward VK; Baird MA; Young SL
J Immunother; 2013 Jan; 36(1):11-9. PubMed ID: 23211625
[TBL] [Abstract][Full Text] [Related]
32. Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model.
Martin ML; Wall EM; Sandwith E; Girardin A; Milne K; Watson PH; Nelson BH
Breast Cancer Res Treat; 2010 Jun; 121(3):753-63. PubMed ID: 19789976
[TBL] [Abstract][Full Text] [Related]
33. Induction of tumour necrosis factor-alpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid.
Philpott M; Baguley BC; Ching LM
Cancer Chemother Pharmacol; 1995; 36(2):143-8. PubMed ID: 7767951
[TBL] [Abstract][Full Text] [Related]
34. Oral activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice.
Zhao L; Kestell P; Ching LM; Baguley BC
Cancer Chemother Pharmacol; 2002 Jan; 49(1):20-6. PubMed ID: 11855749
[TBL] [Abstract][Full Text] [Related]
35. Anti-CD40-induced inflammatory E-cadherin+ dendritic cells enhance T cell responses and antitumour immunity in murine Lewis lung carcinoma.
Zhang Y; Hu X; Hu Y; Teng K; Zhang K; Zheng Y; Hong X; Yu K; Wang Y; Liu L
J Exp Clin Cancer Res; 2015 Feb; 34(1):11. PubMed ID: 25651850
[TBL] [Abstract][Full Text] [Related]
36. Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice.
Ching LM; Zwain S; Baguley BC
Br J Cancer; 2004 Feb; 90(4):906-10. PubMed ID: 14970872
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
Murata R; Overgaard J; Horsman MR
Int J Hyperthermia; 2001; 17(6):508-19. PubMed ID: 11719967
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effect of lymphotactin and interferon gamma-inducible protein-10 transgene expression in T-cell localization and adoptive T-cell therapy of tumors.
Huang H; Xiang J
Int J Cancer; 2004 May; 109(6):817-25. PubMed ID: 15027114
[TBL] [Abstract][Full Text] [Related]
39. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
Murata R; Horsman MR
Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-21-dependent modulation of T cell antigen receptor reactivity towards low affinity peptide ligands in autoreactive CD8(+) T lymphocytes.
Bobbala D; Orkhis S; Kandhi R; Ramanathan S; Ilangumaran S
Cytokine; 2016 Sep; 85():83-91. PubMed ID: 27300756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
